Aller au contenu principal

A new attenuated IBR live vaccine with double genetic deletion gE-tk- is efficacious in front of experimental BoHV-1 infections, even in presence of maternally derived antibodies

Publications
Bovins
Auteurs

Moreno, A.; Casado, C.; Roca, M.; Creixans, O.

IBR (Infectious Bovine Rhinotracheitis) eradication programs in the EU are based mainly on a DIVA (Differentiation of Infected from Vaccinated Animals) strategy by using marker vaccines. So far, all these IBR marker vaccines were based on single deleted BoHV-1 gE- strains: Bovine HerpesVirus-1 strains lacking glycoprotein E.

Télécharger cet article
PDF